Obesity and the Link to Chronic Disease Development
Journal Title: Journal of Obesity and Chronic Diseases - Year 2017, Vol 1, Issue 1
Abstract
In the US, childhood obesity affects approximately 12.5 million children and teens. Changes in obesity prevalence show a rapid increase from the 1960s to the 1980s and 1990s when obesity prevalence among children and teens tripled [1]. Recently, a nationally representative study of children and adolescents in the US, ages 2 to 19 years, showed that the prevalence of obesity from 2011 to 2014 was 17.0% and extreme obesity prevalence was 5.8% [2]. Childhood obesity can also increase risk factors for cardiovascular hypertension, high cholesterol, and diabetes.
Authors and Affiliations
Reza Hakkak, Andrea Bell
Keywords
Related Articles
- EP ID EP322423
- DOI 10.17756/jocd.2016-001
- Views 120
- Downloads 0
The Answer to Why Some Are Obese but Healthy?!
Obesity is a complex issue involving both physical and metabolic dysfunction. Some obese individuals are spared from the unfavorable metabolic disturbances often seen in that condition. Such individuals are referred to a...
A Focus on Motor Competence as Alternative Strategy for Weight Management
The high prevalence of overweight and obesity has been identified as major threat to future public health. Excess body weight not only impairs individual quality of life but is also associated with considerable costs. Th...
Complex Interactions of Obesity, Dairy Food Intake and Genetics of Lactase
Obesity is a growing global problem associated with multiple diseases, often attributed to a western lifestyle and industrialization. Obesity is associated with low grade inflammation and alterations in the colonic micro...
Influence of Vitamin D Deficiency on Cardiometabolic Risk in Obesity
Vitamin D deficiency and dysfunctional adipose tissue are involved in the development of cardiometabolic disturbances (eg, hypertension, insulin resistance, type 2 diabetes mellitus, obesity, and dyslipidemia). We studie...
A Simple Model to Predict Moderate to Severe Steatosis in Obese Liver Donors
Background: In the selection of marginal liver grafts most transplantation centers use a cut-off of 30% macrovesicular steatosis to define an acceptable risk of non-function. The aim of this prospective cohort study was...